Samantha Semenkow
Stock Analyst at Citigroup
(1.30)
# 3,641
Out of 5,032 analysts
48
Total ratings
41.03%
Success rate
-11.17%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Samantha Semenkow
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MLTX MoonLake Immunotherapeutics | Downgrades: Neutral | $72 → $5 | $9.12 | -45.18% | 2 | Sep 30, 2025 | |
| BHVN Biohaven | Initiates: Buy | $28 | $15.95 | +75.55% | 1 | Sep 17, 2025 | |
| ROIV Roivant Sciences | Initiates: Buy | $16 | $17.26 | -7.30% | 1 | Sep 2, 2025 | |
| CABA Cabaletta Bio | Maintains: Buy | $13 → $10 | $2.85 | +250.88% | 4 | Aug 14, 2025 | |
| WVE Wave Life Sciences | Initiates: Buy | $16 | $7.81 | +104.87% | 1 | Jul 16, 2025 | |
| PRME Prime Medicine | Downgrades: Neutral | $10 → $1.5 | $5.45 | -72.48% | 3 | May 27, 2025 | |
| ALLO Allogene Therapeutics | Maintains: Buy | $8 → $4 | $1.23 | +225.20% | 3 | May 15, 2025 | |
| ARGX argenx SE | Maintains: Buy | $796 → $803 | $843.66 | -4.82% | 6 | May 9, 2025 | |
| GPCR Structure Therapeutics | Initiates: Buy | $60 | $27.38 | +119.14% | 1 | May 2, 2025 | |
| BIOA BioAge Labs | Maintains: Neutral | $7 → $5 | $5.18 | -3.47% | 3 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $4.95 | +142.42% | 1 | Dec 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $31 | $20.55 | +50.85% | 2 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $15 | $5.03 | +198.21% | 2 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $80 | $11.70 | +583.76% | 2 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $14 | $4.20 | +233.33% | 6 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $15 | $3.77 | +297.88% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 → $50 | $17.51 | +185.55% | 3 | Sep 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $56 | $25.98 | +115.55% | 3 | Aug 9, 2023 |
MoonLake Immunotherapeutics
Sep 30, 2025
Downgrades: Neutral
Price Target: $72 → $5
Current: $9.12
Upside: -45.18%
Biohaven
Sep 17, 2025
Initiates: Buy
Price Target: $28
Current: $15.95
Upside: +75.55%
Roivant Sciences
Sep 2, 2025
Initiates: Buy
Price Target: $16
Current: $17.26
Upside: -7.30%
Cabaletta Bio
Aug 14, 2025
Maintains: Buy
Price Target: $13 → $10
Current: $2.85
Upside: +250.88%
Wave Life Sciences
Jul 16, 2025
Initiates: Buy
Price Target: $16
Current: $7.81
Upside: +104.87%
Prime Medicine
May 27, 2025
Downgrades: Neutral
Price Target: $10 → $1.5
Current: $5.45
Upside: -72.48%
Allogene Therapeutics
May 15, 2025
Maintains: Buy
Price Target: $8 → $4
Current: $1.23
Upside: +225.20%
argenx SE
May 9, 2025
Maintains: Buy
Price Target: $796 → $803
Current: $843.66
Upside: -4.82%
Structure Therapeutics
May 2, 2025
Initiates: Buy
Price Target: $60
Current: $27.38
Upside: +119.14%
BioAge Labs
Mar 24, 2025
Maintains: Neutral
Price Target: $7 → $5
Current: $5.18
Upside: -3.47%
Dec 2, 2024
Initiates: Buy
Price Target: $12
Current: $4.95
Upside: +142.42%
Aug 9, 2024
Maintains: Buy
Price Target: $27 → $31
Current: $20.55
Upside: +50.85%
Aug 9, 2024
Maintains: Buy
Price Target: $8 → $15
Current: $5.03
Upside: +198.21%
Jun 3, 2024
Reinstates: Buy
Price Target: $80
Current: $11.70
Upside: +583.76%
May 22, 2024
Maintains: Buy
Price Target: $10 → $14
Current: $4.20
Upside: +233.33%
May 9, 2024
Maintains: Buy
Price Target: $16 → $15
Current: $3.77
Upside: +297.88%
Sep 27, 2023
Maintains: Buy
Price Target: $33 → $50
Current: $17.51
Upside: +185.55%
Aug 9, 2023
Maintains: Buy
Price Target: $60 → $56
Current: $25.98
Upside: +115.55%